Ebola has reached Nord-Ubangi in the Democratic Republic of the Congo, with two cases and one death confirmed in the northern province, Congolese authorities said on the 18th of October.[1][2] It is the eighth province affected by the outbreak.[1]

The new cases widen the area health teams must cover in a country already dealing with its largest recorded Ebola outbreak.[3] For families and health workers, the immediate problem is getting infections recognised and people into care, across places where roads and communications can be difficult.[2][3]

What happened⌗

The National Institute for Biomedical Research confirmed the two cases in Nord-Ubangi, according to Reuters.[1] The Associated Press separately reported the Health Ministry’s account: both patients were men in their twenties living in Wapinda health zone, which borders the already affected province of Bas-Uele.[2]

Reuters had first reported the cases on the 15th of October, citing health officials, before the public confirmation on Sunday.[1]

A national situation report covering the period to the 16th of October put the cumulative total at 9,415 confirmed cases and 4,536 deaths, Reuters reported.[1]

Why the new location matters⌗

Nord-Ubangi borders the Central African Republic and sits between Sud-Ubangi and Bas-Uele, two other affected provinces.[2] AP describes poor roads and limited communication networks in the region, where people displaced by armed violence across the border have sought refuge.[2] A provincial boundary on a map says little about how easily a health team can reach a village.

WHO, the World Health Organization, has reported that many deaths are occurring outside treatment centres, pointing to delays in identifying illness and reaching care.[3] Reaching a treatment centre early is part of the medical response.

There are practical ways to bring care closer. In Wamba, a different health zone in Haut-Uele province, epidemiologist Serge Ngalebato told AP that teams introduced periodic home visits because people were afraid to attend hospital.[2] Those visits bring the response closer to people who might otherwise remain outside it.

What is confirmed⌗

  • The new location: Nord-Ubangi is the eighth affected province; two cases and one death have been confirmed.[1]
  • The main burden: the outbreak remains concentrated in eastern DR Congo, with Ituri accounting for 44 of the 67 new confirmed cases in the daily period reported by Reuters.[1]
  • The virus: this outbreak is caused by Bundibugyo virus, one of the different viruses that cause Ebola disease.[3][4]
  • The wider picture: Kenya has also recorded infections, while Uganda’s outbreak was declared over in August.[6][7]

How Ebola spreads⌗

Ebola passes between people through direct contact, through broken skin or the eyes, nose or mouth, with infected blood or other body fluids; contaminated bedding, clothing and surfaces can also transmit infection.[4] Caring for a sick relative, cleaning soiled linen or handling a body during a funeral can therefore involve exposure.[4]

WHO says people do not transmit Ebola before symptoms begin, and the interval between infection and symptoms can range from two to 21 days.[4] Contact tracing means identifying people who may have been exposed and monitoring their health over that period.[4] It is a practical way to find illness earlier, rather than waiting for someone to arrive at hospital.

Early symptoms, including fever, tiredness and muscle pain, can resemble other infections such as malaria, so laboratory testing is important.[4] Bleeding is not present in every patient and may occur later in the illness.[4]

Care and vaccine research⌗

There is no approved vaccine or specific treatment for Bundibugyo virus disease, according to WHO and the German international broadcaster Deutsche Welle (DW).[3][7] Early intensive supportive care, including replacing lost fluids and treating symptoms, can improve survival.[4]

Médecins Sans Frontières, also known as Doctors Without Borders, and its research organisation Epicentre are studying the Ervebo vaccine in frontline workers through a study called BRAVO.[5] Ervebo was developed and licensed for Zaire ebolavirus; the study is intended to establish whether it offers protection in this outbreak.[5] The organisations say frontline workers must continue using protective equipment and following safe-care procedures during the study.[5]

What the spread means beyond DR Congo⌗

Kenya’s health director general, Patrick Amoth, announced an eighth confirmed infection on Sunday, according to a DW report published on the 19th of October.[7] Uganda’s outbreak ended on the 25th of August after 42 days without a new confirmed case, according to ECDC, the European Centre for Disease Prevention and Control.[6]

WHO describes international support involving laboratory testing, surveillance, clinical care, community engagement and supplies, alongside Congolese health authorities.[3] These are concrete tasks: recognising a possible case, testing it, protecting carers and following up exposed people.[3][4]

In its report published on the 8th of October, WHO retained a very high risk assessment for DR Congo, high risk for countries sharing its land borders, and low risk globally.[3]

ECDC also assesses importation risk into the EU and European Economic Area as very low, but its modelling excludes deployed healthcare workers and depends on assumptions about outbreak size and travel.[6]

What remains unclear⌗

The reports confirming the Nord-Ubangi cases do not explain the full chain of infection or how many further infections may remain undetected.[1][2] ECDC notes that Congolese case and death figures remain under review.[6] The effectiveness of Ervebo against Bundibugyo also remains a research question.[5]

Dadbot take⌗

The useful distinction is between how far the outbreak has spread and how well people can be reached. A wider map means more places need the same essential work: finding cases, protecting carers and getting patients into treatment.[3][4]

Sources and caveats⌗

Checked on the 19th of October 2026. National totals above have a cut-off on the 16th; WHO’s quoted risk assessment is from its report published on the 8th. Reuters and AP report official figures; this article does not independently verify laboratory records. DW’s later Kenya update includes AP and Reuters material, so it is not a wholly separate reporting chain.